Synthesis and biological evaluation of 2-(3-Fluoro-4-nitro phenoxy)-N-phenylacetamide derivatives as novel potential affordable antitubercular agents

Molecules

Volumn 17, Issue 2, 2012, Pages 2248-2258

  Ang, Wei ^a,b   Lin, Yan Ni ^b   Yang, Tao ^b   Yang, Jian Zhong ^b   Pi, Wei Yi ^b   Yang, Ying Hong ^c   Luo, You Fu ^b   Deng, Yong ^a   Wei, Yu Quan ^b  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b SICHUAN UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

Author keywords

2 (3 fluoro 4 nitrophenoxy) N phenylacetamide; Affordable; Antitubercular; H 37Rv; Rifampin resistant

Indexed keywords

ACETANILIDE DERIVATIVE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANIMAL; ARTICLE; CELL STRAIN HCT116; CELL STRAIN HEPG2; CERCOPITHECUS; DRUG EFFECT; HELA CELL; HUMAN; IC 50; MYCOBACTERIUM TUBERCULOSIS; SYNTHESIS; TUMOR CELL LINE; VERO CELL;

ACETANILIDES; ANIMALS; ANTITUBERCULAR AGENTS; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; HCT116 CELLS; HELA CELLS; HEP G2 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; VERO CELLS;

EID: 84863159115     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17022248     Document Type: Article

References (12)

1. Murray, J.F. A century of tuberculosis. Am. J. Respir. Crit. Care Med. 2004, 169, 1181-1186. (Pubitemid 38680393)
2. Qian, L.; Montellano, P.R.O. Oxidative activation of thiacetazone by the Mycobacterium tuberculosis flavin monooxygenase EtaA and human FMO1 and FMO3. Chem. Res. Toxicol. 2006, 19, 443-449.
3. Tuberculosis Facts. WHO, 2006. Available online: http://www.who.int/tb/ publications/2006/ tb-factsheet-2006-1-en.pdf (accessed on 23 August 2006).
4. Mital, A.; Negi, V.S.; Ramachandran, U. Synthesis and antimycobacterial activities of certain trifluoromethyl-aminoquinoline derivatives. ARKIVOC 2006, 10, 220-227. (Pubitemid 43570425)
5. Kumar, P.; Narasimhan, B.; Yogeeswari, P.; Sriram, D. Synthesis and antitubercular activities of substituted benzoic acid N'-(substituted benzylidene/furan-2-ylmethylene)-N-(pyridine-3-carbonyl)- hydrazides. Eur. J. Med. Chem. 2010, 45, 6085-6089.
6. Tipparaju, S.K.; Muench, S.P.; Mui, E.J.; Ruzheinikov, S.N.; Lu, J.Z.; Hutson, S.L.; Kirisits, M.J.; Prigge, S.T.; Roberts, C.W.; Henriquez, F.L.; et al. Identification and development of novel inhibitors of toxoplasma gondii enoyl reductase. J. Med. Chem. 2010, 53, 6287-6300.
7. Sun, A.; Prussia, A.; Zhan, W.Q.; Murray, E.E.; Doyle, J.; Cheng, L.T.; Yoon, J.J.; Radchenko,E.V.; Palyulin, V.A.; Compans, R.W.; et al. Nonpeptide inhibitors of measles virus entry. J. Med. Chem. 2006, 49, 5080-5092. (Pubitemid 44260205)
8. 2007143557, 2007.
9. Ananthan, S.; Faaleolea, E.R.; Goldman, R.C.; Hobrath, J.V.; Kwong, C.D.K.; Laughon, B.E.; Maddry, J.A.; Mehta, A.; Rasmussen, L.; Reynolds, R.C.; et al. High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv. Tuberculosis 2009, 89, 334-353.
10. Baker, J.W.; Schumacher, I.; Bachman, G.L.; Roman, D.P.; Tharp, A.L. Halonitroanilides and their bacteriostatic activity. J. Med. Chem. 1966, 9, 428-430.
11. Cheng, T.R.; Wu, Y.T.; Yang, S.T.; Lo, K.H.; Chen, S.K.; Chen, Y.H.; Huang, W.I.; Yuan, C.H.; Guo, C.W.; Huang, L.Y.; et al. High-throughput identification of antibacterials against methicillin-resistant Staphylococcus aureus (MRSA) and the transglycosylase. Bioorg. Med. Chem. 2010, 18, 8512-8529.
12. Pier, G.B.; Delia, P.; Mojgan, A.T.; Francesca, F.; Giulia, S.; Stefania, B.; Romeo, R.; Allan, R.M.; Stefania, G.; Katia, V.; Pier, A.B. N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyl-methoxy-phenyl]-(2- chloro)-50-N-ethylcarboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A2B adenosine receptor. Bioorg. Med. Chem. 2007, 15, 2514-2527.